About
inSignals Neurotech is a University of Porto spin-off company developing innovative solutions to improve therapies, promoting healthier lives and well-being among patients with movement disorders. Founders of inSignals Neurotech include INESC TEC, Prof. João Paulo Cunha - BRAIN lab leader at INESC TEC - and Frontier IP Group specialised in the commercialisation of IP. Our team is developing the first technological solution for quantifying muscular rigidity in patients with neuromuscular disorders: the iHandU technology. Our goal is to ensure the development of solutions that reduce the subjectivity of neurological assessment, supporting clinicians and patients. inSignals is committed to supporting a higher quality of care for Parkinson's Disease, touching the lives of millions of patients and neurologists worldwide.
Technologies
Keywords
Company Information
-
Employees 4
-
Founded 2019
-
Annual Revenue $3000000
-
Total Funding $118979
Location
Porto, Porto District, Portugal, 4000